Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Provention Bio Inc (NQ: PRVB ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Apr 26, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Provention Bio Inc < Previous 1 2 3 4 5 6 Next > Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates August 02, 2021 The month of July was disappointing from the perspective of Food and Drug Administration decisions, as the agency handed down mostly negative verdi... Via Benzinga Is Provention Bio a Bad News Buy? July 16, 2021 There's a good case this biotech stock is now at least somewhat undervalued. Via The Motley Fool Exposures Product Safety The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix July 11, 2021 Biopharma stocks closed the holiday-shortened week lower amid a lack of any significant news flow. On the drug approval front, Provention Bio, Inc. (NASDAQ: PRVB) faced a setback... Via Benzinga Mid-Afternoon Market Update: Dow Tumbles 300 Points; Advaxis Shares Spike Higher July 06, 2021 Toward the end of trading Tuesday, the Dow traded down 0.86% to 34,488.53 while the NASDAQ fell 0.08% to 14,626.98. The S&P also fell, dropping 0.48% to 4,331.47. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs August 01, 2021 Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test July 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:... Via Benzinga Topics Product Recall Exposures COVID-19 Legal Product Safety The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend July 07, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 6) Ambrx Biopharma Inc. (NYSE:... Via Benzinga Here's Why Provention Bio Stock Is Diving Today July 06, 2021 The company's latest letter from the FDA wasn't what investors had hoped for. Via The Motley Fool Exposures Product Safety 61 Biggest Movers From Yesterday July 07, 2021 Gainers BSQUARE Corporation (NASDAQ: BSQR) shares climbed 77.1% to close at $7.05 on Tuesday on abnormally-high volume. The company’s stock dropped around 10% on Friday.... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session July 06, 2021 Gainers Advaxis (NASDAQ:ADXS) shares increased by 43.13% to $0.68 during Tuesday's regular session. The current volume of 106.3 million shares is 1084.49% of Advaxis... Via Benzinga Mid-Day Market Update: Gold Rises Over 1%; Provention Bio Shares Plunge July 06, 2021 Midway through trading Tuesday, the Dow traded down 1.09% to 34,408.75 while the NASDAQ rose 0.01% to 14,641.07. The S&P also fell, dropping 0.60% to 4,326.41. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities 42 Stocks Moving In Tuesday's Mid-Day Session July 06, 2021 Gainers Orbsat Corp. (NASDAQ: OSAT) shares jumped 74% to $9.47. BSQUARE Corporation (NASDAQ: BSQR) shares jumped 48.2% to $5.90 after dropping around 10% on Friday. Bridgeline... Via Benzinga Mid-Morning Market Update: Markets Mostly Lower; ISM Services PMI Falls In June July 06, 2021 Following the market opening Tuesday, the Dow traded down 0.62% to 34,569.49 while the NASDAQ rose 0.19% to 14,667.72. The S&P also fell, dropping 0.27% to 4,340.67. The U.S.... Via Benzinga Topics Stocks Exposures US Equities Why Odonate Therapeutics, Opthea, ALX Oncology, Advaxis and Provention Bio Are Moving Today July 06, 2021 Odonate Therapeutics, Inc. (NASDAQ: ODT), Opthea Limited (NASDAQ: OPT), ALX Oncology Holdings Inc. (NASDAQ: ALXO), Provention Bio, Inc. (NASDAQ: PRVB) and Advaxis, Inc. (NASDAQ:... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday July 06, 2021 Tuesday morning, 51 companies reached new 52-week lows. Noteworthy Highlights: China Life Insurance Co (NYSE:LFC) was the largest company by market cap to set a new... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session July 06, 2021 Gainers Advaxis (NASDAQ:ADXS) stock rose 46.9% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $100.9 million. Axcella... Via Benzinga Provention Bio's Teplizumab Application Receives CRL For Type-1 Diabetes; Stock Drops July 06, 2021 The FDA has issued a Complete Response Letter (CRL) to Provention Bio Inc's (NASDAQ: PRVB) teplizumab marketing application seeking approval for the delay... Via Benzinga Exposures Product Safety 28 Stocks Moving in Tuesday's Pre-Market Session July 06, 2021 Gainers Odonate Therapeutics, Inc. (NASDAQ: ODT) shares rose 38.3% to $4.80 in pre-market trading following 13G from Ikarian Capital showing a 5.2% stake in the company. BSQUARE... Via Benzinga The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures July 02, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1) Alexion Pharmaceuticals, Inc... Via Benzinga Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates July 01, 2021 June was a month of plenty and also turned out to be a fruitful one from the perspective of Food and Drug Administration approvals. Regulatory reviews mostly produced positive... Via Benzinga 20 Stocks Moving in Thursday's Pre-Market Session July 01, 2021 Gainers Alterity Therapeutics Ltd (NASDAQ: ATHE) shares rose 64% to $2.14 in pre-market trading. Alterity Therapeutics recently said it received EU regulatory guidance for ATH434... Via Benzinga The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus June 27, 2021 Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment. Eli Lilly and Company (NYSE: LLY) stood out among big... Via Benzinga Exposures Product Safety Precigen Stock Surges On Positive AG019 Data for Chronic Treatment Of Type 1 Diabetes June 11, 2021 Precigen Inc's (NASDAQ: PGEN) subsidiary Precigen ActoBio announced topline results from the Phase 1b/2a study evaluating AG019 ActoBiotics to treat recent-... Via Benzinga 44 Biggest Movers From Friday June 01, 2021 Gainers Vertex Energy, Inc. (NASDAQ: VTNR) shares jumped 95.7% to close at $7.81 on continued momentum after the company announced it will acquire an Alabama refinery and related... Via Benzinga Why Provention Bio Stock Crashed Today May 28, 2021 An FDA advisory committee vote was a lot closer than anticipated. Via The Motley Fool Exposures Product Safety The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes May 31, 2021 After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-... Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Friday's Intraday Session May 28, 2021 Gainers Organovo Holdings (NASDAQ:ONVO) stock moved upwards by 28.66% to $10.01 during Friday's regular session. Trading volume for this security as of 12:30 EST is 6.... Via Benzinga 38 Stocks Moving In Friday's Mid-Day Session May 28, 2021 Gainers Vertex Energy, Inc. (NASDAQ: VTNR) shares surged 48.6% to $5.93 on continued momentum after the company announced it will acquire an Alabama refinery and related... Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session May 28, 2021 Gainers Iterum Therapeutics (NASDAQ:ITRM) shares moved upwards by 21.13% to $1.49 during Friday's pre-market session. The company's market cap stands at $266.9... Via Benzinga The Daily Biotech Pulse: Biohaven, Bristol-Myers Squibb Snag FDA Approvals, Iterum UTI Drug Review On Track, Centessa Pharmaceuticals Debuts On Nasdaq May 28, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 27) BioCryst Pharmaceuticals,... Via Benzinga Exposures Product Safety < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.